Tenet Healthcare price target raised to $78 from $60 at Mizuho

Mizuho analyst Ann Hynes raised the firm’s price target on Tenet Healthcare to $78 from $60 and keeps a Buy rating on the shares post the Q4 results. The analyst sees upside potential to estimates, driven by better than expected payer mix in acute care, a faster recovery in the surgery center business and contract labor trends. Improving trends in the surgery center segment are key to unlocking multiple expansion for Tenet, the analyst tells investors in a research note.